RBCRX Mutual Fund

NAV$11.96

Fund Essentials - as of Dec 31, 2025

Net Assets
-
Expense Ratio
1.00%
Dividend Yield (Current)
3.72%
Holdings
75
Inception Date
Apr 11, 2022
Fund Family
RBC Global Asset Management (US)
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD-2.92%
1 Year+28.24%
3 Year+15.97%

Asset Allocation

Stocks: 100.00%

Top Holdings

View All →
TickerNameWeight
0700:SZTENCENTHLDGSLTD8.72%
9988:HKAlibaba Group Holding Ltd8.51%
2318:HKPing An Insurance (group) Co. Of China Ltd Class H4.73%
CLF:DBChina Life Insurance Co. Ltd. H Shares3.76%
1093:HKCSPC Pharmaceutical Group Limited Shs3.52%
Top 10 Concentration: 44.31%Report Date: Dec 31, 2025
Download all 75 holdings for RBCRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.72%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

RBCRX Mutual Fund Overview

RBCRX Mutual Fund (RBC China Equity Fund (US) Class R6) is managed by RBC Global Asset Management (US). RBCRX expense ratio is 1.00%, holding 75 positions across sectors including Unknown, Financials, Health Care. Inception date: 2022-04-11.

RBCRX performance shows a YTD return of -2.92%. The 1-year return is 28.24%. RBCRX dividend yield stands at 3.72%, paid annually.

RBCRX top holdings include TENCENTHLDGSLTD (8.7%), Alibaba Group Holding Ltd (8.5%), Ping An Insurance (group) Co. Of China Ltd Class H (4.7%), China Life Insurance Co. Ltd. H Shares (3.8%), CSPC Pharmaceutical Group Limited Shs (3.5%). View all RBCRX holdings, sector breakdown, or dividend history.

RBCRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RBCRX alternatives are available via the screener, along with tax-loss harvesting opportunities.